KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN
On February 15, 2024, Paul Knight, an esteemed analyst at KeyBanc, expressed his positive outlook on Repligen (NASDAQ: RGEN) by ...
© 2024 Stocks Today
Tag: RGEN
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape